CanadaCGM.com Expert Interview with Michael C. Riddell, PhD
Suzanne Lepage, a private health plan strategist with over 20 years in the group insurance industry, is joined by Michael C. Riddell, PhD, Professor, School of Kinesiology and Health Science, Faculty of Health, York University diabetes registry recently published in Diabetic Medicine.
Cost-effectiveness of Real-Time Continuous Glucose Monitoring
Key findings from a cost-effectiveness analysis (CEA) for adults with insulin-treated type 2 diabetes in Canada suggests the use of Dexcom G6 Real-Time Continuous Glucose Monitoring (rtCGM) provides a cost-effective disease management option relative to SMBG. The CEA is built on data from the growing body of evidence that shows rtCGM to be transformative for many people living with diabetes.